TET1 and neoplasm: TET1 is generally considered a tumor suppressor, while it is often down-regulated in multiple malignancies including breast, hepatic, pancreatic, gastric, and prostate cancers [5,14–17], but it has also been reported as a potential oncogene that contributes to aberrant hypomethylation in cancer [18].